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The use of nonspecific polyclonal activation of lymphocytes has long been used as 
a  model for the study of antigen-induced responses.  Essential to the study of bone 
marrow-derived  (B)  cell activation is the ability to reproducibly induce and detect 
antibody production in vitro. Polyclonal activators offer the unique ability to stimulate 
a greater percentage of the total B cell population. In addition to generating a greater 
understanding of B  cell  physiology in  vitro,  tests  that  can  be  used  to  selectively 
analyze human B and thymus-derived (T) cell function represent important tools for 
evaluating the immunological status of patients with various diseases. 
Pokeweed  mitogen  (PWM) a  has  been  extensively  used  to  trigger  the  in  vitro 
production and secretion of immunoglobulin (Ig)  by human B cells.  Workers have 
demonstrated Ig production by measuring intracytoplasmic Ig levels (1), the presence 
of Ig in culture supernates  (2),  and by local hemolysis in gel  (3, 4).  In addition to 
plant lectins, substances derived from bacteria (5, 6) and viruses (7) have been shown 
to be potent polyclonal activators for human B cells. It has recently been shown that 
the Fc region of Ig, whether in the form of an Fc fragment (8-10),  aggregated Ig 
(AHGG)  (11),  or  an  immune complex  (12) can  induce  murine  splenic  B  cells  to 
proliferate and differentiate to polyclonal antibody-secreting cells.  Fc fragment-in- 
duced polyclonal antibody production requires the presence of both macrophages and 
T  cells (10). 
The ability of Fc fragments to stimulate murine B cells prompted investigation for 
their ability to serve as a probe for the study of human B cell activation. The studies 
in this report demonstrate that Fc fragments can serve as a potent polyclonal human 
B cell activator. Furthermore, the cellular requirements for such B cell activation are 
documented. 
* This is publication 2467 from the Department of Immunopathology, Scripps Clinic and Research 
Foundation, La Jolla,  Calif.  This work  was  supported in  part  by  U.S.  Public  Health  Service  grants 
AI07007,  AG00783,  and  AI15761;  American Cancer Society  grant  IM-42J;  and  Biomedical  Research 
Support grant RRO-5514. 
:~ Recipient of U. S. Public Health Service National Research Service Award AI05813. To whom all 
correspondence should be directed, 
l Abbreviations used in this paper:  AHGG, aggregated human gamma globulin;  FCS,  fetal  calf serum; 
PBS,  phosphate-buffered saline;  PBL,  peripheral blood lymphocytes;  PFC, plaque-forming cell;  PHA, 
phytohemagglutinin; PWM, pokeweed mitogen; SRBC, sheep erythrocytes. 
778  J. Exp. M~D. © The Rockefeller University Press • 0022-1007/81/09/0778/13  $1.00 
Volume 154  September 1981  778-790 EDWARD L.  MORGAN AND WILLIAM O.  WEIGLE  779 
Materials and Methods 
Source of Peripheral Blood Lymphocytes (PBL).  Venous  blood was  collected in  heparinized 
Vacutainer tubes (Becton, Dickinson & Co., Oxnard, Calif.) from healthy adult donors of both 
sexes, ranging in age from 22-53 mo. 
Source of Spleen Cells.  Normal  spleen was  obtained  from  a  trauma  patient  through  the 
courtesy of the Department of Pathology, Scripps Clinic and Research Foundation, La Jolla, 
Calif. 
Preparation of PBL.  Heparinized peripheral blood was  diluted with  2  vol of phosphate- 
buffered saline (PBS), 0.001  M  phosphate, pH 7.2, and 0.15 M  NaC1.  The diluted blood was 
then  centrifuged  at  2,500  rpm  for  10  min  to  deplete  platelets  (13).  The  cell  pellet  was 
resuspended to the original volume and the PBL were isolated by Ficoll-Paque density gradient 
centrifugation. Briefly, 30 ml of diluted blood was layered into 15-ml Ficoll-Paque (Pharmacia 
Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J.). The gradient was then centrifuged 
at 2,200  rpm for 30 min at room temperature. The PBL at the interface were collected and 
washed once in PBS +  10% fetal calf serum (FCS) (Gibco Laboratories, Grand Island Biological 
Co., Grand Island, N. Y.) before use. This procedure yielded between  1-2 ×  106 mononuclear 
ceUs/ml whole blood. 
Isolation of Peripheral Blood B and T Cells.  PBL suspensions were enriched for B and T cells by 
the neuraminidase-treated sheep erythrocyte (SRBC) rosetting technique (14). The nonrosetting 
cells were defined as B  cell enriched and  the rosetting cells as T  cell enriched. The T  cell 
populations were subjected to 2,000  rad of irradiation (Gamma Cell 40;  Atomic Energy of 
Canada Ltd., Ottawa, Canada) before use in the in vitro antibody response cultures. 
Preparation of Fc Fragments.  A  human  IgGa myeloma protein was a  gift from Dr. Hans L. 
Spiegelberg, Scripps Clinic and Research Foundation. The IgGI was purified by ammonium 
sulfate  fractionation  followed by DEAE-cellulose chromatography  with  0.01  M  phosphate 
buffer, pH 8, used as the eluent. Fc fragments were obtained by digestion of IgOx with papain 
(Sigma Chemical Co., St. Louis, Mo.) in the presence of L-cysteine (Sigma Chemical Co.) and 
EDTA  (J. T. Baker Chemical Co., Phillipsburg, N.J.)  for 5 h  (15).  Following digestion, the 
material was chromatographed on Sephadex G-100  (Pharmacia Fine Chemicals)  to remove 
any undigested IgG. The Fc and Fab fragments were then separated from each other by DEAE 
chromatography (16). 
Preparation of Fc Subfragments 
(a)  PREPARATION  OF ADHERENT CELL SUPERNATE.  PBL were given 2,000 rad irradiation and 
resuspended  to  a  concentration  of 5  ×  106  cells/ml  RPMI  1640  (Flow Laboratories Inc., 
Rockville, Md.) supplemented with 2 mM L-glutamine, 1% BME vitamins (Gibco Laboratories, 
Grand  Island  Biological Co.),  100  U  penicillin and  100  /~g streptomycin  (Microbiological 
Associates, Bethesda, Md.), and 10% FCS. 1-ml samples were allowed to adhere to tissue culture 
dishes (3001;  Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.) for 1 h in an 
atmosphere of 5% CO2 at 37°C. The cells were washed extensively to remove nonadherent cells 
before the addition of Fe fragments.  100/.tg of Fc in  1 ml of RPMI  1640,  supplemented as 
described above except without serum, was added to the adherent cell monolayer. Supernatant 
material  was  collected  after  1  h  and  centrifuged  at  2,000  rpm  before  chromatographic 
separation. 
(b)  CHROMATOGRAPHIC  SEPARATION.  The adherent cell supernate was chromatographed on 
Sephadex G-75 (Pharmacia Fine Chemicals) column  (1.2  X 60 cm) with a bed volume of 40 
ml. The material was eluted with saline at a  flow rate of 20 ml/h, and  1.0-ml samples were 
collected. The column was calibrated with the following standards: blue dextran (>75,000 tool 
wt)  (Pharmacia Fine Chemicals), deoxyribonuclease (31,000 mol wt)  (Sigma Chemical Co.), 
and lysozyme (14,300  mol wt) (Sigma Chemical Co.). The molecular weight of the biologically 
active material was calculated from  a  plot of the elution  volumes vs.  the logarithm of the 
molecular weight of the standards. 
(C)  AFFINITY  CHROMATOGRAPHY.  Pooled column fractions containing the polyclonally  active 
material were passed over an anti-Fc affinity column, as described previously (10,  17). 780  Fc ACTIVATION  OF HUMAN  B LYMPHOCYTES 
Depletion of Macrophages 
(a)  DEPLETION  BY SEPHADEX  G-10 FILTRATION.  PBL enriched for B cells were filtered through 
columns of Sephadex G-10 (Pharmacia Fine Chemicals) by the method of Ly and Mishell (18). 
Briefly,  2 X  107 cells in 2 ml RPMI  1640 supplemented with 5% FCS were filtered through a 
column containing 9 ml of Sephadex G-10 that was previously equilibrated with RPMI  1640 
+  5% FCS. 
(b)  DEPLETION  BY  PLASTIC  ADHERENCE.  B  cell-enriched populations were adjusted  to 2 × 
107 cells/ml, and 1 ml was allowed to adhere to plastic (3001; Falcon Labware, Div. of Becton, 
Dickinson & Co.) for 1 h, at which time the nonadherent cells were carefully removed. 
PBL Proliferation.  Unseparated PBL, B cell-enriched, and T cell-enriched populations were 
resuspended to 5 X  10  s cells/ml RPMI 1640 (Flow Laboratories Inc., Rockville, Md.) supple- 
mented  with  2  mM  L-glutamine,  1%  BME  vitamins  (Gibco  Laboratories,  Grand  Island 
Biological Co.),  100 U  penicillin and  100/~g  streptomycin  (Microbiological Associates),  and 
10% FCS (Gibco Laboratories, Grand Island Biological Co.). 5 ×  105 cells were cultured with 
PWM (Calbiochem-Behring Corp., American Hoechst Corp., San Diego, Calif.), phytohemag- 
glutinin (PHA; Difco Laboratories, Detroit, Mich.), or Fc fragments in 0.2-ml final volume in 
fiat-bottomed microtiter plates  (3042  Microtest  II; Falcon Labware)  for 3 d  at  37°C  in  an 
atmosphere of 5% CO~ in air.  The amount of proliferation was assessed  by incorporation of 1 
/~Ci of [3H]thymidine (New England Nuclear, Boston, Mass.)  during the last  24 h of culture. 
Polydonal Antibody Production by PBL.  B cell-  and T  cell-enriched  populations were resus- 
pended as described above and mixed together at various ratios in a final volume of 0.3 ml in 
round bottomed Cooke microtiter plates (Dynatech Laboratories Inc., Alexandria, Va.). The 
plates  were incubated  from 2-8 d  at  37°C in  an  atmosphere of 5%  CO2  in  air.  Triplicate 
cultures were harvested and assayed for a plaque-forming response, as described below. 
Plaque-forming Responses.  The in vitro cultures were assayed for direct or IgM plaque-forming 
cells  (PFC)  to SRBC by coupling SRBC onto poly-L-lysine-coated fiat  bottomed microtiter 
plates  (19) or to total Ig-secreting cells by a modification of the protein A plaque assay (20). 
Amplifying sera used in the protein A assay recognized human IgG +  IgM +  IgA and was used 
at a dilution of 1:100. 
Results 
Fc Fragment-induced  Proliferation.  Recent studies have established that Fc fragments 
derived from mammalian Ig induce murine splenic B cells to proliferate (8, 9, 17). To 
determine whether Fc also had the capacity to stimulate  human  PBL to proliferate, 
intact  PBL,  B  cell-enriched  (SRBC  rosette  negative),  and  T  cell-enriched  (SRBC 
rosette  positive)  populations  were  assessed.  The  results  in  Table  I  indicate  that 
untreated  PBL  are  induced  to  proliferate  in  response  to  Fc  fragments  (ninefold 
stimulation)  compared with background controls, whereas Fab fragments are unable 
to  induce  a  proliferative  response.  Moreover,  Fab  fragments  did  not  induce  any 
proliferation  in PBL cultures over a  wide range of concentrations  (data not shown). 
Untreated  PBL also responded to the T  cell mitogen PHA (51-fold stimulation)  and 
to PWM  (25-fold stimulation),  which stimulate  both B and T  cells  (Table I). When 
the  PBL  population  was  enriched  for  B  cells,  the  response  to  Fc  fragments  was 
enhanced  (9-  vs.  15-fold),  the  PHA response  was  reduced  (51-  vs.  7-fold),  and  the 
PWM  response  was  slightly  reduced  (25-  vs.  20-fold)  compared  with  intact  PBL 
cultures.  In  contrast,  when  the  PBL  population  was  enriched  for  T  cells,  the  Fc 
fragment  response  was reduced  to near background levels  (9- vs.  2-fold). The  PHA 
response was enhanced  (51- vs.  112-fold), and the PWM response was approximately 
the same  (25- vs. 24-fold) compared with untreated control responses.  In neither  the 
B  cell-  nor  T  cell-enriched  populations  did  Fab  fragments  induce  a  proliferative 
response. These results indicate that, as in the murine model, Fc fragments stimulate 
human B cells to proliferate. EDWARD  L.  MORGAN  AND WILLIAM O.  WEIGLE  781 
TABLE I 
Fc Fragment-mediated  Activation of Human PBL 
PBL treatment  Stimulator  r lqlTh-,,  ;~1;  ts  j__sm._.ne uptake 
± SE* 
cpm X  lO-a/culture 
None  --  2,001 ±  110 
None  Fab$  2,210 ±  1,099 
None  Fe§  19,250 ± 2,111 
None  PWM I  49,986 + 3,171 
None  PHA¶  102,666 ± 5,280 
B cell-enriched** 
T eell-enriched$$ 
--  1,705 ± 91 
Fab  1,910 + 600 
Fc  26,814 ± 3,157 
PWM  35,000 ±  1,660 
PHA  11,519 ±  1,200 
--  1,213  ±  136 
Fab  1,717 ± 296 
Fc  2,000 ± 200 
PWM  34,200 + 6,700 
PHA  145,922 ± 5,339 
* The response was measured on day 3 of culture. 
$ 1.0 #g Fab/culture. 
§ 1.0 #g Fc/culture. 
[[ 10/Lg PWM/culture. 
¶ 2 #g PHA/cuhure. 
** Sheep erythrocyte rosette-negative cells (B cells). 
$:1: Sheep erythrocyte rosette-positive cells (T cells). 
Fc Fragment-induced  Polyclonal  Antibody Response.  Because  Fc fragments  induce  hu- 
man  peripheral  blood  B  cells  to  proliferate,  experimentation  was  conducted  to 
determine  whether Fc could stimulate  B  cells to secrete polyclonal antibody,  It was 
observed  that  B  cells  could  be  stimulated  to  secrete  polyclonal  antibody  in  the 
presence of Fc fragments (Fig.  1).  1/Lg Fc/cuhure was found to induce the maximum 
response  as  measured  by total  Ig secretion  (protein  A  plaque  assay)  and  by direct 
anti-SRBC response. To determine the optimal day for assaying the in vitro polyclonal 
response, cultures were plaqued from day 2 to day 7 of cuhure. Day 6-7 was found to 
be the optimum time for assaying total Ig secretion and day 5 was optimum  for the 
anti-SRBC plaque-forming response (Fig. 2). 
Preliminary  experiments  indicated  that intact  PBL populations  were inconsistent 
in their ability to produce the polyclonal antibody response  (E.  L.  Morgan,  unpub- 
lished  results).  It  has  been  reported  in  the  PWM  system  that  irradiation  of T  cells 
before their addition  to B cells resulted  in enhanced antibody responses  (10). There- 
fore, varying numbers of irradiated  T  cells were added to the B cell-enriched  (B cells 
+  macrophages)  populations  and  the  polyclonal  antibody  response  was  measured. 
The results show that the B cell-enriched population was unable to secrete polyclonal 
antibody in response to Fc in the absence ofT cells. The addition of twice the number 
ofT cells to B cells (2:1) resulted in the maximum polyclonal antibody response when 
assayed by the protein A  assay, and an equal number of T  cells to B cells produced 
the optimal anti-SRBC  response  (Fig. 3).  It is interesting to note that a  3:1 T  cell to -H 
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Fie.  1.  Dose response of the Fc fragment-mediated polyclonal antibody response by human PBL. 
Total Ig secretion was measured on day 6 from cultures that contained l ×  10  5 B ceils and 2 X 10  5 
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FIG.  2.  Kinetics of the Fc fragment-mediated polyclonal antibody response by human PBL.  1 #g 
Fc/culture was used, and the response was measured from day 4 to day 7. The B:T cell ratios were 
identical to those in Fig.  1. 
B  cell ratio completely abrogated  the anti-SRBC  response,  whereas total Ig secretion 
was only marginally reduced. 
To examine  the variability of PBL  from  different  individuals  to be stimulated  by 
Fc fragments, experiments were performed comparing  15 individuals for their ability 
to respond  to Fc fragments.  The results  in Fig. 4  reveal that,  as observed with PWM 
responses  (20),  marked  variation  exists  from  individual  to  individual.  The  mean 
response  for total Ig secretion was 4,500  PFC  and  for the direct  anti-SRBC  response 
was  145  PFC. EDWARD  L.  MORGAN  AND  WILLIAM  O.  WEIGLE  783 
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Fig.  1. 
Because  the  murine  model  used  splenic  lymphocytes, it  became  important  to 
determine whether lymphocytes derived from human spleen were capable of mounting 
a polyclonal antibody response to Fc fragments. Normal spleen from a trauma patient 
was  found  to  produce  a  significant  polyclonal  anti-SRBC  PFC  response  in  the 
presence of Fc fragments (Table II). These results indicate that splenic B cells as well 
as peripheral blood B cells can be stimulated by Fc fragments. However, the optimal 
conditions for generation of the splenic polyclonal antibody response are currently 
unknown because of the limited availability of normal spleen, and therefore must 
await further investigation. 
Fc Subfragment-induced Polyclonal Antibody Response.  Macrophages have been shown 
to be essential for the Fc fragment-mediated proliferative (9) and polyclonal antibody 784  Fc  ACTIVATION  OF  HUMAN  B  LYMPHOCYTES 
TABLE  II 
Fc Fragment-mediated Polyclonal Antibody Response of Human Splenic 
Lymphocytes 
Direct anti-SRBC PFC/10 n 
Spleen cells*  Fc  ± SE, 
gg/culture 
+  -  15±7 
+  10  390 :t:  14 
* 5  X  10  5 cells/0.3 ml culture volume. 
:~ The response was measured on day 3 ofcuhure. 
TABLE  III 
Inability of Macrophage-depleted PBL to Respond to Fc Fragments 
Treatment 
B cells*  T  cells::[: 
Fc§  Ig-secreting cells/108 B 
cells ±  SE[[ 
None  None  -  305 ±  48 
None  None  +  1,322 ±  110 
G-10  None  -  50 ±  13 
G-10  None  +  90 ±  47 
Adherence  None  -  85 ±  26 
Adherence  None  +  115 ±  11 
*  1 X  10SB cells/culture. 
1 X  10  5 T  cells/culture. 
§  1 #g Fc/culture. 
[] The response was measured on day 6 of culture. 
(10) responses in the murine model. To assess the role of peripheral blood monocytes 
in the Fc response, PBL populations were depleted of monocytes by Sephadex G-10 
filtration or by plastic adherence before culturing with Fc fragments. The results show 
that  either  depletion  method  is  equally  efficient  in  that  the  polyclonal  antibody 
response was  reduced to background levels  (Table III).  These results indicate that 
adherent monocytes are required for the Fc-mediated polyclonal antibody response. 
To further define the role of the adherent monocytes in the Fc-mediated polyclonal 
antibody response, irradiated adherent cells were cultured with or without Fc frag- 
ments for 1 h; the supernatant material was then collected and assayed on monocyte- 
depleted cultures. The results indicate that the Fc supernate could stimulate mono- 
cyte-depleted cultures, whereas Fc fragments were unable to stimulate a  polyclonal 
response  (Fig.  5).  Moreover,  the  polyclonal  antibody  response  obtained  with  Fc 
supernate was equivalent to that obtained with Fc fragments in cultures containing 
monocytes. Supematant material collected from monocytes cultured in the absence of 
Fc  fragments was  nonstimulatory  (Fig.  5).  Because murine  macrophages  digest  Fc 
fragments  into  biologically active Fc  subfragments  (17),  the  human  monocyte Fc 
supernate was chromatographed on Sephadex G-75 and  the column fractions were 
assessed for their ability to stimulate polyclonal antibody production in monocyte- 
depleted  PBL  cultures.  The  results  in  Fig.  fi  reveal  that  the  biologically  active 
component in the Fc supernate has ~ 19,000 tool wt. No biological activity was found 
to be associated with the original Fc material because the cell population was depleted 
of monocytes before culturing.  To  further characterize  the  19,000  tool  wt  active EDWARD  L.  MORGAN  AND  WILLIAM  O.  WEIGLE  785 
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material, it was filtered through an anti-Fc fragment affinity column and the effluent 
and eluate were assessed for polyclonal activity. The results in Table IV show that the 
19,000  tool wt component induces a pronounced polyclonal response compared with 
the control culture (2,096 vs. 56 PFC). When this material was subjected to affinity- 
column filtration, the polyclonal activating material was found in the eluate, indicat- 
ing that  it bound to, and could be eluted from, the anti-Fc affinity column  (1,912 
PFC). One passage through the column reduced the polyclonal response from 2,096 
to 272 PFC (87% reduction). These results indicate that the 19,000 mol wt polyelonal 
activation in the Fc monocyte supernate is derived from the Fc fragment. 
Discussion 
Human B cells derived from peripheral blood are induced to proliferate and secrete 
polyclonal antibody upon stimulation with Fc fragments derived from human Ig. The 786  Fc ACTIVATION OF  HUMAN B LYMPHOCYTES 
TABLE IV 
Recovery of the Polyclonal-activating Material from an Anti-Fc Affinity 
Column 
Supernate source  Treatment  Ig-secreting cells/ 
108* B cells ± SE 
None  None  56 ± 6 
Fc-monocyte:~  None  2,096 ± 48 
Fc-monocyte  Anti-Fc column effluent  272 -t- 12 
Fc-monocyte  Ant i-Fc column eluate  1,912 ± 89 
Monocyte§  None  60 ± 9 
* The response was measured on day 6 of culture. 
:l: The  19,000 mol wt  fraction from the  Sephadex G-75 chromatographic 
separation of Fc monocyte  supernate. 
§ Supernate from  monocytes  incubated without Fc fragments. 
addition of Fc fragments, but not Fab fragments or intact Ig, to in vitro lymphocyte 
cultures results in a significant polyclonal antibody response measured by either anti- 
SRBC or total Ig plaque-forming responses. 
The Fc fragment-mediated human polyclonal antibody, but  not the proliferative 
response, requires  the  presence of T  cells.  The optimum B  cell to T  cell  ratio was 
found  to  be  1:2  for  the  protein  A  response  and  1:1  for  the  anti-SRBC  response. 
Preliminary experiments revealed that antibody responses were significantly higher 
when irradiated  (2,000 rad) T  cells were used. This finding is consistent with that of 
Fauci  et  al.  (20)  and  Dosch et al.  (21),  who have shown  that  human  T  helper cell 
activity is more resistant  to irradiation  than T  suppressor cell activity. The require- 
ment for T  cells in the human Fc polyclonal antibody response is reminiscent of the 
results observed in the murine model  (10,  12,  22,  23).  In the murine system, T  cells 
provide a  second  or differentiative signal  to  the  B  cell  (10),  which,  in  conjunction 
with the Fc proliferative signal, induces the potyclonal antibody response. Moreover, 
it was shown by Thoman et al. (22, 23) that the T  cell requirement can be substituted 
for by a soluble T  cell factor (Fc)TRF derived from T  cells after stimulation with Fc 
fragments.  Similar T  cell requirements have been reported for polyclonal antibody 
production  by human B  cells to PWM  (24-27).  The pathway for polyclonal B  cell 
activation  by  PWM  may  be  different  from  that  of Fc  fragment  because  PWM 
stimulates both B and T  cells to proliferate, whereas Fc fragments induce only B cells 
to  proliferate.  An  additional  example of T  cell  participation  in  B  cell  polyclonal 
activation was reported by Shinohara  and Kern  (28), who found that when T  cells 
were  added  to  rabbit  B  cells,  an  enhanced  lipopolysaccharide-induced  polyclonal 
antibody response occurred. Goodman and Weigle (29) have extended this observation 
to the  murine  model, showing  that  T  cells produce  a  modest  enhancement  of the 
lipopolysaccharide  polyclonal  antibody  response.  More  recently,  Levitt  et  al.  (30) 
found that under appropriate culture conditions, the addition of T  cells to lipopoly- 
saccharide-stimulated human peripheral blood B cells resulted in the development of 
IgG and IgA plasma cells and an increase in IgM plasma cells. 
Adherent  monocytes are required  in addition to T  cells to obtain an Fc fragment- 
mediated polyclonal antibody response by human B cells. The accessory cell popula- 
tion was characterized as being plastic adherent, resistant to irradiation, SRBC-rosette 
negative, and depleted  by Sephadex G-10 filtration.  The function of the monocytes EDWARD L.  MORGAN AND  WILLIAM O.  WEIGLE  787 
is to cleave the Fc fragments into biologically active Fc subfragments. Incubation of 
Fc fragments with adherent monocytes results in a supernate that has the capacity to 
induce a polyclonal antibody response in monocyte-depleted cultures. Sephadex G-75 
chromatographic separation  of the supernate  revealed that  the biologically active 
material had ~ 19,000 mol wt. That the 19,000 mol wt subfragment was derived from 
the original Fc fragment was proven by the ability of the subfragment to be bound to 
and eluted from an anti-Fc affinity column. The  requirement  for T  cells was  not 
bypassed by the use of Fc subfragments.  Murine splenic  macrophages  have been 
shown to be essential for the Fc fragment-mediated proliferative (9, 17) and polyclonal 
(10)  responses.  Murine macrophage digestion of Fc results in the production of Fc 
subfragments  with  ~~,000  mol  wt  (17).  The  significance in  the  size  differences 
between Fc subfragments generated with human monocytes and murine macrophages 
is unknown and is currently being studied. Passwell et al. (31) have recently reported 
that  Fc fragments increase endogenous production  of prostaglandin  E  by human 
monocyte monolayers. In addition, they observed (31) that Fc induces the secretion 
of IgM  into  culture  supernates,  and  that  the  IgM  secretion  was  independent  of 
monocytes. The apparent difference between the results reported here and those of 
Passwell et al.  (31) could be explained by the culture conditions used. The require- 
ments for monocytes in the PWM-induced polyclonal antibody response have also 
been a point of contention. It has been reported that the PWM polyclonal response 
is both independent of (32, 33) and dependent on (34, 35) the presence of monocytes. 
Rosenberg  and  Lipsky  (36)  found  that  the  monocyte requirement  of the  PWM 
response  was  dependent  upon  the  cell  density~in culture.  The  greatest  degree  of 
monocyte dependence occurred when limited cell-to-cell interaction occurred  (i.e., 
flat-bottomed wells or smaller numbers of cells per culture). 
The  observation  that  Fc fragments  (8-10),  aggregated human  gamma globulin 
(11),  and  antigen-antibody complexes  (12) all  trigger B  cells to secrete polyclonal 
antibody, and the fact that in all cases the biologically active mediator is a  small 
subfragment derived from the Fc molecule, strongly suggests that the pathways of 
activation are the same. Regulation of both in vivo and in vitro lymphocyte activation 
via  immune  complexes  could  occur  by  the  generation  of biologically  active  Fc 
subfragments. That Fc fragments have the capacity to regulate both in vivo and in 
vitro humoral (37) and T  cell-mediated (38) responses has recently been reported. Fc 
fragments  were  shown  to  potentiate  antigen-specific  antibody  formation  and  to 
enhance antigen and allogeneic cell-induced T  cell proliferation. The fact that  Fe 
fragments can function as a  polyclonal T  cell activator for human B cells does not 
necessarily mean that Fc can act as a human adjuvant. Experimentation is currently 
in progress to answer this question. 
Summary 
Fc fragments derived from human immunoglobulin were found to be capable of 
inducing both a proliferative and polyclonal antibody response in human peripheral 
blood  lymphocyte cultures.  The  cell  population  proliferating  in  response  to  Fc 
fragments belongs to the B cell lineage. Expression of polyclonal antibody formation 
requires  the  presence  of both  adherent  monocytes and  T  cells.  The  role  of the 
monocyte is to enzymatically cleave the Fc fragment into 19,000 mol wt Fc subfrag- 
ments that  are  then able  to  induce polyclonal antibody secretion.  Stimulation of 788  Fc ACTIVATION OF HUMAN B LYMPHOCYTES 
polyclonal antibody production by Fc subfragments occurs in the absence of adherent 
monocytes but still requires the presence of T  cells. 
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